ATONF yields 2.74% · PFE yields 6.20%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, ATONF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ATONF + PFE for your $10,000?
Anton Oilfield Services Group, an investment holding company, provides oilfield engineering and technical services for oil companies in the People's Republic of China and internationally. It operates through four segments: Inspection Services, Oilfield Management Services, Oilfield Technical Services, and Drilling Rig Services. The company offers inspection and repair, intelligent monitoring, and digital and intelligent management services of various equipment and facilities for the operation of customers' oil and gas field equipment, facilities, and assets; management general contracting, including reservoir support, operation management, production operation, logistics, and third-party service provider management, as well as health, safety, and environment services; capacity construction; oilfield development management; and oilfield operation and maintenance services, such as engineering contracting, commissioning, and operation and maintenance management services for oilfield assets of oil companies. It also provides geological, drilling, well completion, and stimulation technology services, as well as asset leasing services; and drilling and well workover services that require drilling rigs. In addition, the company manufactures rod casings; and provides construction services. Anton Oilfield Services Group was founded in 1999 and is based in Beijing, China. Anton Oilfield Services Group is a subsidiary of Pro Development Holdings Corp.
Full ATONF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.